Solara Active Pharma Sciences
SOLARANSE

Solara Active Pharma Sciences

₹459.800.70 (0.15%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
442.00
Today’s high
459.80
52 week low
422.00
52 week high
734.40
Open price
442.00
Previous close
459.10
Live volume
21,750
Lower circuit
367.30
Upper circuit
550.90

Fundamentals

Market Cap
₹2,036Cr
ROE
0.51%
P/E Ratio(TTM)
-87.20
EPS(TTM)
-5.28
P/B Ratio
1.34
Dividend Yield
0.00%
Industry P/E
31.44
Book Value
344.59
Debt to Equity
0.51
Face Value
10

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About

Solara Active Pharma Sciences Limited is a pure-play API manufacturer, offering a wide range of APIs and contract manufacturing services.;
MD/CEO
Mr. Poorvank Purohit
Founded in
2017
NSE symbol
SOLARA
Industry

Shareholding Pattern

Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Promoters
42.00%
Retail And Others
39.76%
Foreign Institutions
14.59%
Other Domestic Institutions
2.46%
Mutual Funds
1.18%

Mutual Funds Invested (1)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
Innova CaptabINNOVACAP
₹702.30
-1.65 (0.23%)
L
    H
    4,026.3530.413.94
    ₹379.30
    -13.45 (3.42%)
    L
      H
      3,666.0140.95.03
      Aarti DrugsAARTIDRUGS
      ₹345.20
      -1.20 (0.35%)
      L
        H
        3,169.8115.662.16
        ₹289.40
        +0.70 (0.24%)
        L
          H
          2,912.2058.24.61
          Livesquawk
          Solara Active Pharma faces ₹161.9 Cr tax demand for AY20 from Thane authority. The company plans to appeal and expects no significant operational impact.
          Livesquawk
          Solara Active Pharma Sciences reported a Q3 net loss of ₹174M, down from a profit of ₹80M YoY.
          2026
          6
          Feb
          Quarterly Result
          Release date
          2025
          5
          Nov
          Quarterly Result
          Release date
          25
          Jul
          Quarterly Result
          Release date
          2024

          15
          May
          Rights Entitlement
          Ex date
          1:3
          Ratio

          1 rights eligible for every 3 existing shares held
          Ratio1:3
          Offer price₹375.00
          Ex date15 May ‘24
          Record date15 May ‘24
          Announcement date9 May ‘24

          9
          May
          Rights Entitlement
          Announced
          1:3
          Ratio

          1 rights eligible for every 3 existing shares held
          Ratio1:3
          Offer price₹375.00
          Ex date15 May ‘24
          Record date15 May ‘24
          Announcement date9 May ‘24
          Events calendar
          View upcoming events in other stocks